CDKN2A/B deletion was the most frequent abnormality, detected in 46/170 cases (38/150 B‐Cell ALL; Figure 1A), consistent with previous Mexican reports [20, 47]. This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.